---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-020336"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T05:33:10.717709+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q1 2025: revenue down 34% to $115.7M, net loss $0.8M; Q2 guidance weak

## Summary
- Revenue fell 33.8% to $115.7M; active earning coaches down 32.8% to 25,400.
- Net loss of $0.8M vs. net income of $8.3M a year ago; diluted EPS -$0.07.
- Gross margin held at 72.8%; operating loss $1.3M vs. operating income $7.9M.
- Q2 2025 revenue guidance $85M-$105M; loss per share $0.00-$0.55.
- Cash, equivalents, and investments $164.6M; no debt.

## SEC filing metadata
- accession: 0001628280-25-020336
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828025020336/0001628280-25-020336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828025020336/med-20250428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-020336
- JSON: https://secwatch.observer/filing/0001628280-25-020336.json
- Plain text: https://secwatch.observer/filing/0001628280-25-020336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.